JP2001342139A - System for preventing pollionosis and mitigating its symptom - Google Patents

System for preventing pollionosis and mitigating its symptom

Info

Publication number
JP2001342139A
JP2001342139A JP2000166252A JP2000166252A JP2001342139A JP 2001342139 A JP2001342139 A JP 2001342139A JP 2000166252 A JP2000166252 A JP 2000166252A JP 2000166252 A JP2000166252 A JP 2000166252A JP 2001342139 A JP2001342139 A JP 2001342139A
Authority
JP
Japan
Prior art keywords
ozone
pollionosis
symptom
hay fever
preventing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000166252A
Other languages
Japanese (ja)
Inventor
Minoru Takei
稔 武井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2000166252A priority Critical patent/JP2001342139A/en
Publication of JP2001342139A publication Critical patent/JP2001342139A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a system for preventing pollionosis and mitigating its symptom, capable of effectively preventing the pollionosis from being manifested, even when pollens invade the body of a human, and capable of easily giving effects on the human body so as to mitigate the symptom, without carrying out complicated treatments such as periodical dosage and administration of medicaments, etc. SOLUTION: This system for preventing the pollionosis and mitigating the symptom comprises making the human inhale the air containing ozone generated from an ozone generator in a specified concentration so as to prevent the pollionosis from being manifested and mitigate the symptom of the pollionosis. Further the system comprises filling living spaces of the human with the air containing the ozone generated from the ozone generator in the specified concentration so as to prevent the pollionosis from being manifested and mitigate the symptom of the pollionosis.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、花粉症の発生を予
防したり、花粉症の症状を緩和したりする花粉症予防及
び症状緩和システムに関する。
The present invention relates to a hay fever prevention and symptom alleviation system for preventing the occurrence of hay fever and alleviating the symptoms of hay fever.

【0002】[0002]

【従来の技術】花粉症は、発作性反復性のくしゃみ、鼻
水、鼻づまり、目の痒みの四大症状に代表されるアレル
ギー性疾患の一つであり、その主な原因は春先に大気中
を飛散する花粉にある。この花粉が鼻腔や目の粘膜に付
着すると、そこで吸水膨潤して、その外膜が割れ、そこ
から無数の抗原物質が放出する。この抗原物質が粘膜を
通して体内に浸透し、急激なアレルギー反応すなわち花
粉症を引き起こす。
2. Description of the Related Art Hay fever is one of the allergic diseases represented by the four major symptoms of paroxysmal recurrent sneezing, runny nose, stuffy nose, and itchy eyes. Is in the pollen that scatters. When the pollen adheres to the nasal cavity and mucous membrane of the eyes, it absorbs and swells there, breaking its outer membrane and releasing countless antigenic substances therefrom. This antigenic substance penetrates into the body through mucous membranes, causing a sudden allergic reaction, ie, hay fever.

【0003】[0003]

【発明が解決しようとする課題】この花粉症の予防方法
としては、マスクやメガネなどを用いて、体内に花粉が
浸入するのを物理的に阻止しようとするものがある。ま
た、紫外線やコロナ放電を用いて花粉を無害化するもの
もある。しかしながら、全ての花粉を物理的に阻止した
り、無害化することは困難である。花粉症の発生を予防
したり、治療方法として、最も一般的なものは、体内に
浸入した抗原物質によってアレルギー反応が発生しない
ようにする薬剤等を経口や経鼻にて体内に吸収させて体
内で作用させるものがある。しかしながら、このような
薬剤は毎日毎時決められた時間に所定量のものを継続的
に服用したり投与しなければその効果を維持することが
できない。また、薬剤による効果も個人差があり、薬剤
によって副作用が生じるなどの問題もある。
As a method for preventing hay fever, there is a method for physically preventing the invasion of pollen into the body by using a mask or glasses. Some pollutants are rendered harmless using ultraviolet light or corona discharge. However, it is difficult to physically block or render all pollen physically harmless. The most common method of preventing or treating hay fever is to absorb orally or nasally a drug or the like into the body that prevents an allergic reaction from occurring due to antigen substances that have entered the body. There is something that works with. However, the effect of such a drug cannot be maintained unless a predetermined amount of the drug is continuously taken or administered at a predetermined time every day. In addition, there is also a problem that the effect of the drug varies from person to person, and the drug causes side effects.

【0004】本発明は、上述の点に鑑みてなされたもの
であり、体内に花粉が浸入しても花粉症の発生を有効に
予防することができ、薬剤等のように定期的な服用や投
与などと言った煩雑な処置を行わなくても簡単に人体に
作用させて症状を緩和することのできる花粉症予防及び
症状緩和システムを提供することを目的とする。
[0004] The present invention has been made in view of the above points, and can effectively prevent the occurrence of hay fever even if pollen enters the body. It is an object of the present invention to provide a hay fever prevention and symptom alleviating system which can easily act on a human body and alleviate symptoms without performing complicated treatments such as administration.

【0005】[0005]

【課題を解決するための手段】請求項1に記載された花
粉症予防及び症状緩和システムは、オゾン発生装置から
発生する所定濃度のオゾンを含む空気を人に吸引させる
ことによって花粉症の発生を予防したり、花粉症の症状
を緩和したりするものである。
According to a first aspect of the present invention, there is provided a hay fever prevention and symptom alleviating system for controlling the occurrence of hay fever by causing a person to inhale air containing a predetermined concentration of ozone generated from an ozone generator. It prevents or alleviates the symptoms of hay fever.

【0006】請求項2に記載された花粉症予防及び症状
緩和システムは、オゾン発生装置から発生する所定濃度
のオゾンを含む空気で人の居住空間を満たすことによっ
て花粉症を予防したり、花粉症の症状を緩和したりする
ものである。
According to a second aspect of the present invention, there is provided a hay fever prevention and symptom alleviating system for preventing hay fever by filling a living space of a person with air containing a predetermined concentration of ozone generated from an ozone generator. Or to alleviate the symptoms.

【0007】オゾン発生装置を用いて低濃度のオゾンを
発生し、請求項1に記載のもののように人にそれを吸引
させたり、請求項2に記載のもののように人の居住空間
を所定濃度のオゾンで満たしたりすることによって、低
濃度のオゾンが体内に吸収され、オゾンによって目や鼻
の粘膜が暴露され、細胞組織に作用し、杉花粉から放出
される無数の抗原物質にらる急激なアレルギー反応が緩
和され、花粉症の症状が発生しなくなる。
An ozone generator is used to generate low-concentration ozone and cause a person to inhale the ozone as described in claim 1 or to make a living space of a person have a predetermined concentration as described in claim 2. By filling with ozone, low concentrations of ozone are absorbed into the body, and the ozone exposes the mucous membranes of the eyes and nose, acts on cellular tissues, and is exposed to the myriad of antigenic substances released from cedar pollen. Allergic reactions are alleviated, and hay fever symptoms do not occur.

【0008】[0008]

【発明の実施の形態】以下、本発明の実施の形態を図面
を用いて説明する。図1は、本発明の花粉症予防及び症
状緩和システムで使用されるオゾン発生装置の概略構成
を示す図である。図1(a)はオゾン発生装置の内部構
造を示す断面図であり、図1(b)及び(c)は図1
(a)のオゾン発生装置を右側から見た側面図である。
なお、図1(b)及び(c)は、内部部品(混合比調節
板6)の位置が異なる場合を示している。
Embodiments of the present invention will be described below with reference to the drawings. FIG. 1 is a diagram showing a schematic configuration of an ozone generator used in the hay fever prevention and symptom alleviation system of the present invention. FIG. 1A is a cross-sectional view showing the internal structure of the ozone generator, and FIGS.
It is the side view which looked at the ozone generator of (a) from the right side.
FIGS. 1B and 1C show the case where the position of the internal component (mixing ratio adjusting plate 6) is different.

【0009】このオゾン発生装置は送気用ファン1、本
体筐体2、オゾン混合排出部3、紫外線ランプ4、安定
器5及び混合比調節板6から構成される。送気用ファン
1は、安定器5から供給される電力に応じて所定の回転
数で回転し、毎分所定流量の空気を本体筐体2に送風す
る。本体筐体2は、断面形状が正方形をしており、その
両端部が開放した空洞直方体をしており、腐食及び耐熱
に強い耐食性材料、例えばステンレスで構成されてい
る。
This ozone generator comprises an air supply fan 1, a main body casing 2, an ozone mixing / discharging section 3, an ultraviolet lamp 4, a stabilizer 5, and a mixing ratio adjusting plate 6. The air supply fan 1 rotates at a predetermined rotation speed in accordance with the electric power supplied from the ballast 5, and blows a predetermined flow rate of air to the main body housing 2 per minute. The main body housing 2 has a square cross section and a hollow rectangular parallelepiped at both ends, and is made of a corrosion-resistant material that is resistant to corrosion and heat, for example, stainless steel.

【0010】本体筐体2の内部空洞には、ほぼ中央付近
に仕切板21が設けられ、この仕切板21によって上下
2系統に区切られた流体経路22,23が形成されてい
る。この2系統の流体経路22,23は、互いに断面積
が等しいので、送気用ファン1からはほぼ同じ流量の空
気が送風されることになる。流体経路22側の仕切板2
1上には紫外線ランプ4が設けられおり、その反対側す
なわち流体経路23側の仕切板21上には安定器5が設
けられている。
A partition plate 21 is provided near the center of the internal cavity of the main body casing 2, and fluid paths 22 and 23 are formed by the partition plate 21 and are divided into upper and lower systems. Since the two fluid paths 22 and 23 have the same cross-sectional area, the air supply fan 1 blows air at substantially the same flow rate. Partition plate 2 on fluid path 22 side
An ultraviolet lamp 4 is provided on 1, and a ballast 5 is provided on the opposite side, that is, on a partition plate 21 on the fluid path 23 side.

【0011】紫外線ランプ4は、波長184.9nmの
紫外線を発生する水銀ランプなどで構成される。紫外線
ランプ4は電力線51を介して安定器5に接続される。
安定器5は電力線51を介して紫外線ランプ4に所定の
電力を供給する。混合比調節板6は、流体経路22,2
3を通過し、排出される流体の混合の割合を調節するも
のであり、ステンレス製の板で構成される。オゾン混合
排出部3では、流体経路22を通過したオゾンを含む空
気と、流体経路23を通過した空気とを混合し、所定濃
度に希釈されたオゾンを含む空気をその排出口32から
排出する。
The ultraviolet lamp 4 is composed of a mercury lamp or the like that generates ultraviolet light having a wavelength of 184.9 nm. The ultraviolet lamp 4 is connected to the ballast 5 via a power line 51.
The ballast 5 supplies a predetermined power to the ultraviolet lamp 4 via the power line 51. The mixing ratio adjusting plate 6 is connected to the fluid paths 22 and 2.
3, which adjusts the mixing ratio of the fluid to be discharged and is constituted by a stainless steel plate. The ozone mixing / discharging unit 3 mixes the air containing ozone that has passed through the fluid path 22 and the air that has passed through the fluid path 23, and discharges the air containing ozone diluted to a predetermined concentration from the outlet 32.

【0012】オゾン混合排出部3は、混合比調節板6を
上下方向にスライド可能なガイド溝を有する。混合比調
節板6はこのオゾン混合排出部3のガイド溝に沿った所
定位置に固定される。流体経路22の排出口付近には張
出板34が設けられ、流体経路23の排出口付近には張
出板35が設けられている。従って、流体経路22から
排出されるオゾンを含む空気は、矢印線36のように混
合比調節板6の上側開口部を通過し、張出板34の下側
開口部を通過し、矢印線38のように張出板35の上側
開口すなわち排出口32から排出する。一方、流体経路
23から排出される空気は、矢印線37のように混合比
調節板6の下側開口部を通過し、矢印線38のように張
出板35の上側開口部すなわち排出口32から排出す
る。流体経路22から排出されるオゾンを含む空気と、
流体経路23から排出される通常の空気とは、矢印線3
6と矢印線37との衝突する付近すなわら張出板34と
張出板35との間で混合され、所定濃度に希釈されたオ
ゾンを含む空気となって排出口32から排出されるよう
になる。
The ozone mixing / discharging section 3 has a guide groove which allows the mixing ratio adjusting plate 6 to slide up and down. The mixing ratio adjusting plate 6 is fixed at a predetermined position along the guide groove of the ozone mixing and discharging unit 3. An overhang plate 34 is provided near the outlet of the fluid path 22, and an overhang plate 35 is provided near the outlet of the fluid path 23. Therefore, the air containing ozone discharged from the fluid passage 22 passes through the upper opening of the mixing ratio adjusting plate 6 as shown by the arrow line 36, passes through the lower opening of the overhang plate 34, and passes through the arrow line 38. As described above, the sheet is discharged from the upper opening of the overhang plate 35, that is, the discharge port 32. On the other hand, the air discharged from the fluid passage 23 passes through the lower opening of the mixing ratio adjusting plate 6 as indicated by an arrow 37, and the upper opening of the overhanging plate 35, ie, the outlet 32 as indicated by an arrow 38. Discharged from Air containing ozone discharged from the fluid path 22;
The normal air discharged from the fluid path 23 is indicated by an arrow 3
6 near the collision of the arrow line 37 with the overhanging plate 34 and the overhanging plate 35 so that the air containing ozone diluted to a predetermined concentration is discharged from the outlet 32. become.

【0013】排出口32から排出される空気のオゾン濃
度の調節は混合比調節板6の位置を適宜調整することに
よって行う。すなわち、混合比調節板6が流体経路22
の排出口を塞ぐような位置にある場合には、送気用ファ
ン1から送風された空気は、流体経路23だけを通過し
て排出口32から排出されるようになるので、その排出
空気のオゾン濃度は限りなくゼロに近い値を示すように
なる。逆に、混合比調節板6が流体経路23の排出口を
塞ぐような位置にある場合には、送気用ファン1から送
風された空気は、流体経路22だけを通過して排出口3
2から排出されるようになるので、その排出空気のオゾ
ン濃度は最大値を示すようになる。なお、このオゾン濃
度の最大値が労働環境基準に従った上限濃度(0.1p
pm)となるようにオゾン発生装置を設計しておくこと
が望ましい。
The ozone concentration of the air discharged from the outlet 32 is adjusted by appropriately adjusting the position of the mixing ratio adjusting plate 6. That is, the mixing ratio adjusting plate 6 is
When the air is blown from the air supply fan 1, the air blown from the air supply fan 1 passes only through the fluid path 23 and is discharged from the discharge port 32. The ozone concentration shows a value close to zero as much as possible. Conversely, when the mixing ratio adjusting plate 6 is at a position that closes the discharge port of the fluid path 23, the air blown from the air supply fan 1 passes only through the fluid path 22 and passes through the discharge port 3.
2, the ozone concentration of the discharged air has a maximum value. Note that the maximum value of the ozone concentration is the upper limit concentration (0.1 p
pm) is desirably designed.

【0014】例えば、混合比調節板6が図1(b)又は
(c)に示すような位置にある場合には、排出口32か
ら排出される空気のオゾン濃度は、混合比調節板6によ
って塞がれた流体経路22の排出口の面積と流体経路2
3の排出口の面積比にほぼ比例したものとなる。図1
(b)の場合には、面積比は約3:7であり、オゾン濃
度は約0.03ppmとなり、図1(c)に示すように
ほぼ中央付近に位置する場合には、面積比は約5:5と
なり、オゾン濃度は最大値の半分の約0.05ppmと
なる。なお、送気用ファン1の回転数を制御し、流量を
制御してオゾン濃度を調整することも可能である。
For example, when the mixing ratio adjusting plate 6 is located at a position as shown in FIG. 1B or 1C, the ozone concentration of the air discharged from the outlet 32 is controlled by the mixing ratio adjusting plate 6. Area of outlet of blocked fluid path 22 and fluid path 2
3 is almost proportional to the area ratio of the discharge ports. FIG.
In the case of (b), the area ratio is about 3: 7, and the ozone concentration is about 0.03 ppm. When the ozone concentration is almost in the vicinity of the center as shown in FIG. 5: 5, and the ozone concentration is about 0.05 ppm, which is half of the maximum value. The ozone concentration can be adjusted by controlling the rotation speed of the air supply fan 1 and controlling the flow rate.

【0015】図1に示すようなオゾン発生装置を用い
て、低濃度のオゾンを発生し、人の居住空間を所定濃度
のオゾンで満たす。また、排出口32付近に顔を近づけ
て、所定時間呼吸するようにしてもよい。これによっ
て、低濃度のオゾンが体内に吸収され、オゾンによって
目や鼻の粘膜が暴露され、細胞組織に作用し、杉花粉か
ら放出される無数の抗原物質による急激なアレルギー反
応が緩和され、花粉症の症状が発生しなくなる。
A low-concentration ozone is generated by using an ozone generator as shown in FIG. 1, and a living space of a person is filled with a predetermined concentration of ozone. Alternatively, the face may be brought close to the outlet 32 and breathing may be performed for a predetermined time. As a result, low concentrations of ozone are absorbed into the body, the ozone exposes the mucous membranes of the eyes and nose, acts on cell tissues, and alleviates the sudden allergic reaction caused by the myriad antigens released from cedar pollen. The symptoms of the disease no longer occur.

【0016】なお、上述の実施の形態のオゾン発生装置
にタイマーを付けて、毎日所定時間だけ作動するように
してもよい。また、図1に示したオゾン発生装置以外の
オゾン発生装置を用いても同様に花粉症の予防や症状の
緩和効果があることは言うまでもない。さらに、上述の
実施の形態では、紫外線ランプ4として波長184.9
nmの紫外線を発生するものを例に説明したが、18
4.9nmと253.7nmの両方の波長にピークを持
つ紫外線を発生するものを用いてもよいし、又は、流体
経路23側に253.7nmの波長を発生する紫外線ラ
ンプを別途設けてもよい。花粉に対して波長253.7
nmの紫外線が照射されると、この紫外線の作用によっ
て、花粉が不活性化されて無害化する。従って、オゾン
の人体に対する作用と、紫外線による花粉に対する作用
との両方の効果によって花粉症の予防及び症状の緩和が
効果的に行われる。
A timer may be added to the ozone generator of the above-described embodiment so that the device operates every day for a predetermined time. It goes without saying that using an ozone generator other than the ozone generator shown in FIG. 1 also has the effect of preventing hay fever and alleviating the symptoms. Further, in the above embodiment, the ultraviolet lamp 4 has a wavelength of 184.9.
Although an example in which ultraviolet light of nm is generated is described,
One that generates ultraviolet rays having peaks at both the wavelengths of 4.9 nm and 253.7 nm may be used, or an ultraviolet lamp that generates a wavelength of 253.7 nm may be separately provided on the fluid path 23 side. . Wavelength 253.7 for pollen
When ultraviolet rays of nm are irradiated, pollen is inactivated and rendered harmless by the action of the ultraviolet rays. Therefore, both the effect of ozone on the human body and the effect of ultraviolet light on pollen effectively prevent hay fever and alleviate symptoms.

【0017】[0017]

【発明の効果】本発明によれば、体内に花粉が浸入して
も花粉症の発生を有効に予防することができ、薬剤等の
ように定期的な服用や投与などと言った煩雑な処置を行
わなくても簡単に人体に作用させて症状を緩和すること
できるという効果がある。
According to the present invention, it is possible to effectively prevent the occurrence of hay fever even when pollen invades the body, and to carry out complicated treatments such as regular taking and administration such as drugs. This has the effect that it can be easily applied to the human body to alleviate the symptoms without performing.

【図面の簡単な説明】[Brief description of the drawings]

【図1】 本発明の花粉症予防及び症状緩和システムで
使用されるオゾン発生装置の概略構成を示す図
FIG. 1 is a diagram showing a schematic configuration of an ozone generator used in a hay fever prevention and symptom alleviation system of the present invention.

【符号の説明】[Explanation of symbols]

1…送気用ファン 2…本体筐体 3…オゾン混合排出部 4…紫外線ランプ 5…安定器 6…混合比調節板 DESCRIPTION OF SYMBOLS 1 ... Air supply fan 2 ... Main body housing 3 ... Ozone mixing discharge part 4 ... Ultraviolet lamp 5 ... Stabilizer 6 ... Mixing ratio adjusting plate

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 オゾン発生装置から発生する所定濃度の
オゾンを含む空気を人に吸引させることによって花粉症
の発生を予防したり、花粉症の症状を緩和したりするこ
とを特徴とする花粉症予防及び症状緩和システム。
1. A hay fever characterized by preventing the occurrence of hay fever or alleviating the symptoms of hay fever by causing a person to suck air containing a predetermined concentration of ozone generated from an ozone generator. Prevention and symptom relief system.
【請求項2】 オゾン発生装置から発生する所定濃度の
オゾンを含む空気で人の居住空間を満たすことによって
花粉症を予防したり、花粉症の症状を緩和したりするこ
とを特徴とする花粉症予防及び症状緩和システム。
2. A hay fever characterized by preventing hay fever or alleviating the symptoms of hay fever by filling a living space of a person with air containing a predetermined concentration of ozone generated from an ozone generator. Prevention and symptom relief system.
JP2000166252A 2000-06-02 2000-06-02 System for preventing pollionosis and mitigating its symptom Pending JP2001342139A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000166252A JP2001342139A (en) 2000-06-02 2000-06-02 System for preventing pollionosis and mitigating its symptom

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000166252A JP2001342139A (en) 2000-06-02 2000-06-02 System for preventing pollionosis and mitigating its symptom

Publications (1)

Publication Number Publication Date
JP2001342139A true JP2001342139A (en) 2001-12-11

Family

ID=18669599

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000166252A Pending JP2001342139A (en) 2000-06-02 2000-06-02 System for preventing pollionosis and mitigating its symptom

Country Status (1)

Country Link
JP (1) JP2001342139A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018024546A (en) * 2016-08-09 2018-02-15 ウシオ電機株式会社 Ozone generator
JP2020068995A (en) * 2018-10-30 2020-05-07 ウシオ電機株式会社 Gas processing device

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001182346A (en) * 1999-12-28 2001-07-06 Daikin Ind Ltd Sleeping module

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001182346A (en) * 1999-12-28 2001-07-06 Daikin Ind Ltd Sleeping module

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018024546A (en) * 2016-08-09 2018-02-15 ウシオ電機株式会社 Ozone generator
WO2018030144A1 (en) * 2016-08-09 2018-02-15 ウシオ電機株式会社 Ozone generation device
CN109562937A (en) * 2016-08-09 2019-04-02 优志旺电机株式会社 Ozone generating-device
CN109562937B (en) * 2016-08-09 2019-08-20 优志旺电机株式会社 Ozone generating-device
US10556029B2 (en) 2016-08-09 2020-02-11 Ushio Denki Kabushiki Kaisha Ozone generation device
JP2020068995A (en) * 2018-10-30 2020-05-07 ウシオ電機株式会社 Gas processing device
EP3875121A4 (en) * 2018-10-30 2021-12-29 Ushio Denki Kabushiki Kaisha Gas processing device
US11325095B2 (en) 2018-10-30 2022-05-10 Ushio Denki Kabushiki Kaisha Gas processing device
JP7206810B2 (en) 2018-10-30 2023-01-18 ウシオ電機株式会社 gas processor

Similar Documents

Publication Publication Date Title
US7045152B2 (en) Treating pulmonary disorders with gaseous agent causing repletion of GSNO
US3949743A (en) Medicated vapor production method and apparatus
EP0806216B1 (en) A dosing device for adding an additive gas or liquid to breathing gas in an anaesthesia machine or ventilator
BR9913178A (en) Oral liquid mucoadhesive compositions
TWM492749U (en) Anti-explosion gas generator for health
USRE33465E (en) Method for reducing the duration of the common cold
US6528081B1 (en) Nasal spray liquid
JP5584713B2 (en) Nasal drops based on sodium azulenesulfonate
JP2001342139A (en) System for preventing pollionosis and mitigating its symptom
AU2012267620B2 (en) Pressurized Vessel of Nitric Oxide (NO)
Bracher et al. Targeted aerosolized delivery of ascorbate in the lungs of chlorine-exposed rats
CA2923793C (en) Carbon dioxide and saline nasal delivery methods and delivery devices
Kurta et al. Acute nickel carbonyl poisoning
JP7048700B1 (en) Air purification device
US20220040365A1 (en) Air disinfection chamber
KR20230047584A (en) Space purification and sterilization system by Plazma of Air-circulation type
EP4387681A1 (en) Air purification and disinfection apparatus and methods of use
Kimmel et al. Influence of acid aerosol droplet size on structural changes in the rat lung caused by acute exposure to sulfuric acid and ozone
CN117940172A (en) Device for disinfecting an air flow via UV-C radiation and auxiliary ventilation system comprising such a device
Sheppard Mechanisms of airway responses to inhaled sulfur dioxide
RU2540496C1 (en) Composition for nasal application, based therapeutic agent and method for using same
KR102556934B1 (en) Fullcare vacuum negative pressure system
Afshari et al. Chemical Risk without Concurrent External Exposure!
US20220280422A1 (en) Solubilized melatonin
IT202100021659A1 (en) Topical composition and its use for the nasal treatment of rhinitis

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070529

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100928

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110405